Abstract
Purpose
Ischemia–reperfusion (IR) injury is inevitable after liver transplantation and liver resection with inflow occlusion. Sevoflurane has been widely used during hepatobiliary surgery and was reported to exhibit preconditioning (PreC) properties against hepatic IR injury; however, its postconditioning (PostC) properties remain unknown. This study examined whether a clinically applicable dose of sevoflurane has PostC and PreC properties against hepatic IR injury and roles of heme oxygenase-1 (HO-1).
Methods
Warm ischemia was induced in male Wistar rats, excluding the sham group, for 1 h, followed by 3 h of reperfusion. Group C received propofol from 60 min before ischemia until the end of the experimental procedure. In the SPreC and SPostC groups, propofol was replaced by 2.5% sevoflurane for 30 min from 35 min before ischemia in the SPreC group and for 30 min from 5 min before reperfusion in the SPostC group. The SPreC+Z and SPostC+Z groups received a HO-1 inhibitor, zinc protoporphyrin (Znpp), 60 min before ischemia, and sevoflurane PreC and PostC were induced.
Results
Serum aspartate aminotransferase, alanine aminotransferase, and lactic dehydrogenase levels, and histological damage scores in the SPreC and SPostC groups were significantly lower than those in group C. Inhibiting HO-1 with Znpp partially blocked these protective effects of sevoflurane. Sevoflurane PreC and PostC significantly increased the number of HO-1-positive Kupffer cells in comparison with group C, and Znpp prevented sevoflurane-induced HO-1 expression.
Conclusion
PostC and PreC by sevoflurane at a clinically applicable dose have equally protective effects against hepatic IR injury by increasing HO-1 expression.
Similar content being viewed by others
References
Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, Dematteo RP, Tuorto S, Wuest D, Blumgart LH, Fong Y. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg. 2003;237:860–9 (discussion 869–870).
de Boer MT, Molenaar IQ, Porte RJ. Impact of blood loss on outcome after liver resection. Dig Surg. 2007;24:259–64.
Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia–reperfusion injury. Am J Surg. 2001;181:160–6.
Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology. 2003;125:1480–91.
Yan S, Jin LM, Liu YX, Zhou L, Xie HY, Zheng SS. Outcomes and mechanisms of ischemic preconditioning in liver transplantation. Hepatobil Pancreat Dis Int. 2010;9:346–54.
Suyavaran A, Thirunavukkarasu C. Preconditioning methods in the management of hepatic ischemia reperfusion–induced injury: update of molecular and future perspectives. Hepatol Res. 2017;47:31–48.
Theodoraki K, Karmaniolou I, Tympa A, Tasoulis MK, Nastos C, Vassiliou I, Arkadopoulos N, Smyrniotis V. Beyond preconditioning: postconditioning as an alternative technique in the prevention of liver ischemia–reperfusion injury. Oxid Med Cell Longev. 2016. https://doi.org/10.1155/2016/8235921.
de Rougemont O, Lehmann K, Clavien PA. Preconditioning, organ preservation, and postconditioning to prevent ischemia–reperfusion injury to the liver. Liver Transpl. 2009;15:1172–82.
Wang N, Lu JG, He XL, Li N, Qiao Q, Yin JK, Ma QJ. Effects of ischemic postconditioning on reperfusion injury in rat liver grafts after orthotopic liver transplantation. Hepatol Res. 2009;39:382–90.
Dal Ponte C, Alchera E, Follenzi A, Imarisio C, Prat M, Albano E, Carini R. Pharmacological postconditioning protects against hepatic ischemia/reperfusion injury. Liver Transpl. 2011;17:474–82.
Shawky HM, Younan SM, Rashed LA, Shoukry H. Effect of recombinant erythropoietin on ischemia–reperfusion induced apoptosis in rat liver. J Physiol Biochem. 2012;68:19–28.
Toyoda T, Tosaka S, Tosaka R, Maekawa T, Cho S, Eguchi S, Nakashima M, Sumikawa K. Milrinone-induced postconditioning reduces hepatic ischemia–reperfusion injury in rats: the roles of phosphatidylinositol 3-kinase and nitric oxide. J Surg Res. 2014;186:446–51.
Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, Jochum W, Spahn DR, Graf R, Clavien PA. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg. 2008;248:909–18.
Zhou SP, Jiang P, Liu L, Liu H. Protective effect of sevoflurane on hepatic ischemia/reperfusion injury in the rat: a dose–response study. Eur J Anaesthesiol. 2013;30:612–7.
Morita T, Ishikawa M, Sakamoto A. Identical microRNAs regulate liver protection during anaesthetic and ischemic preconditioning in rats: an animal study. PLoS One. 2015. https://doi.org/10.1371/journal.pone.0125866.
Zhang WX, Yin W, Zhang L, Wang LH, Bao L, Tuo HF, Zhou LF, Wang CC. Preconditioning and postconditioning reduce hepatic ischemia–reperfusion injury in rats. Hepatobil Pancreat Dis Int. 2009;8:586–90.
Zeng Z, Huang HF, Chen MQ, Song F, Zhang YJ. Contributions of heme oxygenase-1 in postconditioning-protected ischemia–reperfusion injury in rat liver transplantation. Transp Proc. 2011;43:2517–23.
Lv X, Yang L, Tao K, Liu Y, Yang T, Chen G, Yu W, Lv H, Wu F. Isoflurane preconditioning at clinically relevant doses induce protective effects of hemo oxygenase-1 on hepatic ischemia reperfusion in rats. BMC Gastroenterol. 2011. https://doi.org/10.1186/1471-230x-11-31.
Hirata N, Kanaya N, Kamada N, Kimura S, Namiki A. Differential effects of propofol and sevoflurane on ischemia-induced ventricular arrhythmias and phosphorylated connexin 43 protein in rats. Anesthesiology. 2009;110:50–7.
Carmichael FJ, Crawford MW, Khayyam N, Saldivia V. Effect of propofol infusion on splanchnic hemodynamics and liver oxygen consumption in the rat. A dose–response study. Anesthesiology. 1993;79:1051–60.
Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, Zaky J, Melinek J, Lassman CR, Kolls JK, Alam J, Ritter T, Volk HD, Farmer DG, Ghobrial RM, Busuttil RW, Kupiec-Weglinski JW. Upregulation of hemo oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest. 1999;104:1631–9.
Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Transplantation. 1993;55:1265–72.
Guo JY, Yang T, Xg Sun, Zhou NY, Li FS, Long D, Lin T, Li PY, Feng L. Ischemic postconditioning attenuates liver warm ischemia–reperfusion injury through Akt-eNOS-NO-HIF pathway. J Biomed Sci. 2011. https://doi.org/10.1186/1423-0127-18-79.
Schmeding M, Neumann UP, Boas-Knoop S, Spinelli A, Neuhaus P. Erythropoietin reduces ischemia–reperfusion injury in the rat liver. Eur Surg Res. 2007;39:189–97.
Satoh K, Kume M, Abe Y, Uchinami H, Yakubouski SV, Takahashi T, Sato T, Yamamoto Y. Implication of protein kinase A for a hepato-protective mechanism of milrinone pretreatment. J Surg Res. 2009;155:32–9.
Beck-Schimmer B, Breitenstein S, Bonvini JM, Lesurtel M, Ganter M, Weber A, Puhan MA, Clavien PA. Protection of pharmacological postconditioning in liver surgery: results of a prospective randomized controlled trial. Ann Surg. 2012;256:837–44 (discission 844–845).
Beck-Schimmer B, Roth Z’graggen B, Booy C, Köppel S, Spahn DR, Schläpfer M, Schadde E. Sevoflurane protects hepatocytes from ischemic injury by reducing reactive oxygen species signaling of hepatic stellate cells: translational findings based on a clinical trial. Anesth Analg. 2018;127:1058–65.
Song X, Zhang N, Xu H, Cao L, Zhang H. Combined preconditioning and postconditioning provides synergic protection against liver ischemic reperfusion injury. Int J Biol Sci. 2012;8:707–18.
Farombi EO, Surh YJ. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol. 2006;39:479–91.
Liu B, Qian JM. Cytoprotective role of heme oxygenase-1 in liver ischemia reperfusion injury. Int J Clin Exp Med. 2015;8:19867–73.
Wei L, Chen WY, Hu T, Tang YX, Pan BB, Jin M, Kong GY. Effect and mechanism of propofol in hepatic ischemia/reperfusion injury of rat. Eur Rev Med Pharmacol Sci. 2017;21:3516–22.
Xu Z, Yu J, Wu J, Qi F, Wang H, Wang Z, Wang Z. The effects of two anesthetics, propofol and sevoflurane, on liver ischemia/reperfusion injury. Cell Physiol Biochem. 2016;38:1631–42.
Slankamenac K, Breitenstein S, Beck-Schimmer B, Graf R, Puhan MA, Clavien PA. Does pharmacological conditioning with the volatile anaesthetic sevoflurane offer protection in liver surgery? HPB (Oxford). 2012;14:854–62.
Yang LQ, Tao KM, Liu YT, Cheung CW, Irwin MG, Wong GT, Lv H, Song JG, Wu FX, Yu WF. Remifentanil preconditioning reduces hepatic ischemia–reperfusion injury in rats via inducible nitric oxide synthase expression. Anesthesiology. 2011;114:1036–47.
Criado AB, Gómez e Segura IA. Reduction of isoflurane MAC by fentanyl or remifentanil in rats. Vet Anaesth Analg. 2003;30:250–6.
Smul TM, Stumpner J, Blomeyer C, Lotz C, Redel A, Lange M, Roewer N, Kehl F. Propofol inhibits desflurane-induced preconditioning in rabbits. J Cardiothorac Vasc Anesth. 2011;25:276–81.
Zaugg M, Wang L, Zhang L, Lou PH, Lucchinetti E, Clanachan AS. Choice of anesthetic combination determines Ca2+ leak after ischemia–reperfusion injury in the working rat heart. Favorable versus adverse combinations. Anesthesiology. 2012;116:648–57.
Acknowledgements
The authors are grateful to Dr. Katsuya Matsuda (Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan) and Dr. Suntaro Sato (Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan) for their useful suggestions for histopathology and immunohistology examinations, and statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Shiraishi, S., Cho, S., Akiyama, D. et al. Sevoflurane has postconditioning as well as preconditioning properties against hepatic warm ischemia–reperfusion injury in rats. J Anesth 33, 390–398 (2019). https://doi.org/10.1007/s00540-019-02642-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-019-02642-4